|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 14 |
FusionGeneSummary for A2M_EPN2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: A2M_EPN2 | Fusion gene ID: 14 | Hgene | Tgene | Gene symbol | A2M | EPN2 | Gene ID | 2 | 22905 |
| Gene name | alpha-2-macroglobulin | epsin 2 | |
| Synonyms | A2MD|CPAMD5|FWP007|S863-7 | EHB21 | |
| Cytomap | 12p13.31 | 17p11.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | alpha-2-macroglobulinC3 and PZP-like alpha-2-macroglobulin domain-containing protein 5alpha-2-M | epsin-2EPS-15-interacting protein 2Eps15 binding protein | |
| Modification date | 20180519 | 20180522 | |
| UniProtAcc | P01023 | O95208 | |
| Ensembl transtripts involved in fusion gene | ENST00000318602, ENST00000542567, | ENST00000441293, ENST00000314728, ENST00000347697, ENST00000395618, ENST00000575595, ENST00000395620, ENST00000395626, ENST00000571254, | |
| Fusion gene scores | * DoF score | 10 X 9 X 4=360 | 9 X 9 X 5=405 |
| # samples | 11 | 10 | |
| ** MAII score | log2(11/360*10)=-1.71049338280502 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/405*10)=-2.01792190799726 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: A2M [Title/Abstract] AND EPN2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | A2M | GO:0001869 | negative regulation of complement activation, lectin pathway | 12538697 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BF849872 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000318602 | ENST00000441293 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000318602 | ENST00000314728 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000318602 | ENST00000347697 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000318602 | ENST00000395618 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000318602 | ENST00000575595 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000318602 | ENST00000395620 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000318602 | ENST00000395626 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000318602 | ENST00000571254 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000542567 | ENST00000441293 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000542567 | ENST00000314728 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000542567 | ENST00000347697 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000542567 | ENST00000395618 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000542567 | ENST00000575595 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000542567 | ENST00000395620 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000542567 | ENST00000395626 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
| intron-intron | ENST00000542567 | ENST00000571254 | A2M | chr12 | 9243885 | - | EPN2 | chr17 | 19184805 | + |
Top |
FusionProtFeatures for A2M_EPN2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| A2M | EPN2 |
| Is able to inhibit all four classes of proteinases by aunique 'trapping' mechanism. This protein has a peptide stretch,called the 'bait region' which contains specific cleavage sitesfor different proteinases. When a proteinase cleaves the baitregion, a conformational change is induced in the protein whichtraps the proteinase. The entrapped enzyme remains active againstlow molecular weight substrates (activity against high molecularweight substrates is greatly reduced). Following cleavage in thebait region, a thioester bond is hydrolyzed and mediates thecovalent binding of the protein to the proteinase. | Plays a role in the formation of clathrin-coatedinvaginations and endocytosis. {ECO:0000269|PubMed:10567358}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for A2M_EPN2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for A2M_EPN2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for A2M_EPN2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | A2M | P01023 | DB00515 | Cisplatin | Alpha-2-macroglobulin | small molecule | approved |
| Hgene | A2M | P01023 | DB08888 | Ocriplasmin | Alpha-2-macroglobulin | biotech | approved |
| Hgene | A2M | P01023 | DB00102 | Becaplermin | Alpha-2-macroglobulin | biotech | approved|investigational |
| Hgene | A2M | P01023 | DB01593 | Zinc | Alpha-2-macroglobulin | small molecule | approved|investigational |
| Hgene | A2M | P01023 | DB00626 | Bacitracin | Alpha-2-macroglobulin | small molecule | approved|vet_approved |
Top |
RelatedDiseases for A2M_EPN2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | A2M | C0002395 | Alzheimer's Disease | 3 | CTD_human |
| Hgene | A2M | C0011570 | Mental Depression | 2 | PSYGENET |
| Hgene | A2M | C0011581 | Depressive disorder | 2 | PSYGENET |
| Hgene | A2M | C0024121 | Lung Neoplasms | 2 | CTD_human |
| Hgene | A2M | C0009375 | Colonic Neoplasms | 1 | CTD_human |
| Hgene | A2M | C0019202 | Hepatolenticular Degeneration | 1 | CTD_human |
| Hgene | A2M | C0023890 | Liver Cirrhosis | 1 | CTD_human |
| Hgene | A2M | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Hgene | A2M | C0024115 | Lung diseases | 1 | CTD_human |
| Hgene | A2M | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
| Hgene | A2M | C0206669 | Hepatocellular Adenoma | 1 | CTD_human |
| Hgene | A2M | C2239176 | Liver carcinoma | 1 | CTD_human |
| Hgene | A2M | C2609414 | Acute kidney injury | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|